Information:
Fel:
ID
20287
Beskrivning
Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease.; ODM derived from: https://clinicaltrials.gov/show/NCT00036218
Länk
https://clinicaltrials.gov/show/NCT00036218
Nyckelord
Versioner (1)
- 2017-02-19 2017-02-19 -
Uppladdad den
19 februari 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Parkinson Disease NCT00036218
Eligibility Parkinson Disease NCT00036218
- StudyEvent: Eligibility
Similar models
Eligibility Parkinson Disease NCT00036218
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
parkinson
Item
parkinson's disease of less than 7 years duration
boolean
C0030567 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,2])
hoehn and yahr scale stage
Item
modified hoehn and yahr scale stages 1 through 3.
boolean
C4274318 (UMLS CUI [1])
age
Item
age greater than or equal to 30 years old.
boolean
C0001779 (UMLS CUI [1])
contraceptive methods and gender
Item
men or women (women of childbearing potential must have a negative pregnancy test at screen) and both must use adequate contraceptive methods.
boolean
C0700589 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
C0079399 (UMLS CUI [2])
compliance
Item
patients who are willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures.
boolean
C1321605 (UMLS CUI [1])
atypical parkinsons disease
Item
atypical parkinson's disease syndromes due to drugs, metabolic disorders, encephalitis, or degenerative diseases.
boolean
C1868596 (UMLS CUI [1])
levodopa
Item
levodopa received for 1-year accumulated interval in the last two years.
boolean
C0023570 (UMLS CUI [1])
dopamine agonist or catechol-o-methyl transferase inhibitors
Item
dopamine agonist medications or catechol-o-methyl transferase inhibitors in the 30 days prior to baseline.
boolean
C0178601 (UMLS CUI [1])
C2917201 (UMLS CUI [2])
C2917201 (UMLS CUI [2])
unstable dose regimes
Item
unstable dose regimes of hypnotics, anxiolytics or antidepressants
boolean
C4081662 (UMLS CUI [1])
dementia
Item
dementia
boolean
C0497327 (UMLS CUI [1])
stereotaxic brain surgery
Item
history of stereotaxic brain surgery, psychosis or active epilepsy within past year.
boolean
C0455610 (UMLS CUI [1,1])
C0085203 (UMLS CUI [1,2])
C0033975 (UMLS CUI [2])
C0014544 (UMLS CUI [3])
C0085203 (UMLS CUI [1,2])
C0033975 (UMLS CUI [2])
C0014544 (UMLS CUI [3])
study subject participation status
Item
participation in clinical trial within the previous 30 days.
boolean
C2348568 (UMLS CUI [1])
malignant melanoma or history of melanoma
Item
malignant melanoma or history of melanoma
boolean
C0025202 (UMLS CUI [1])
C0262926 (UMLS CUI [2,1])
C0025202 (UMLS CUI [2,2])
C0262926 (UMLS CUI [2,1])
C0025202 (UMLS CUI [2,2])
illness
Item
significant medical or psychiatric condition.
boolean
C0221423 (UMLS CUI [1])